Tuesday, October 14, 2008 7:29:03 PM
Date : 10/14/2008 @ 2:32PM
Source : Edgar (US Regulatory)
Stock : (NEXM)
Quote : 0.13 -0.01 (-7.14%) @ 4:40PM
- Statement of Changes in Beneficial Ownership (4)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
MAY JACOB 2. Issuer Name and Ticker or Trading Symbol
NEXMED INC [ NEXM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __ X __ Other (specify below)
owns over 5% of securities
(Last) (First) (Middle)
4525 HARDING ROAD, STE 309 3. Date of Earliest Transaction (MM/DD/YYYY)
6/5/2008
(Street)
NASHVILLE, TN 37205
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 6/20/2008 P 4001 A $1.12 5847005 D
Common Stock 6/23/2008 P 5550 A $1.12 5852555 D
Common Stock 6/24/2008 P 2100 A $1.12 5854655 D
Common Stock 6/25/2008 P 7900 A $1.18 5862555 D
Common Stock 6/26/2008 P 3100 A $1.192 5865655 D
Common Stock 6/27/2008 P 8000 A $1.181 5873655 D
Common Stock 6/30/2008 P 3000 A $1.22 5876655 D
Common Stock 7/11/2008 P 8000 A $1.25 5884655 D
Common Stock 7/11/2008 P 10000 A $1.295 5894655 D
Common Stock 7/14/2008 P 200 A $1.12 5894855 D
Common Stock 7/11/2008 P 3500 A $1.28 5898355 D
Common Stock 7/14/2008 P 10000 A $1.15 5908355 D
Common Stock 9/17/2008 P 50000 A $1.62 5958355 D
Common Stock 9/25/2008 P 50000 A $1.57 6008355 D
Common Stock 9/25/2008 P 1508701 A $0.542 7517056 D
Common Stock 9/17/2008 P 50000 A $0.167 7567056 D
Common Stock 9/17/2008 P 100000 A $0.158 7667056 D
Common Stock 9/19/2008 P 150000 A $0.16 7817056 D
Common Stock 9/25/2008 P 70245 A $0.15 7887301 D
Common Stock 9/26/2008 P 6000 A $0.141 7893301 D
Common Stock 9/30/2008 P 110000 A $0.122 8003301 D
Common Stock 10/1/2008 P 12299 A $0.122 8015600 D
Common Stock 10/2/2008 P 25000 A $0.139 8040600 D
Common Stock 6/5/2008 P 10640 A $1.23 8051240 D
Common Stock 7/14/2008 P 10000 A $1.18 8061240 D
Common Stock 7/14/2008 P 2200 A $1.2 8063440 D
Table II - Derivative Securities Beneficially Owned ( e.g.
, puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 8. Price of Derivative Security
(Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MAY JACOB
4525 HARDING ROAD
STE 309
NASHVILLE, TN 37205
owns over 5% of securities
Signatures
s/Jacob May 10/14/2008
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Recent SEEL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
- Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM